 Home > Active Ingredient News > Antitumor Therapy > Eur Urol Focus: Chromosomal instability of cell-free DNA can serve as a prognostic biomarker for androgen deprivation in the treatment of metastatic hormone-sensitive prostate cancer

Eur Urol Focus: Chromosomal instability of cell-free DNA can serve as a prognostic biomarker for androgen deprivation in the treatment of metastatic hormone-sensitive prostate cancer

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

tnbc breast cancer

cancer dots

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Although patients with metastatic hormone-sensitive prostate cancer (mHSPC) can be treated with androgen deprivation therapy (ADT), metastases can still progress to anti-prostate cancer (mCRPC

Recently, researchers from South Korea published an article in Eur Urol Focus investigating the role

This prospective study included 75 patients with elevated prostate-specific antigens, analyzed their cell-free DNA (cfDNA) in pre-treatment plasma samples, and performed low-depth whole-genome sequencing of cfDNA to identify CNAs

Of the 22 IScore-positive patients, 86.

Different factors predict the development of castration resistance

Taken together, IScore can serve as a biomarker

Original Source:

Chung Un Lee， Eunhae Cho， Junnam Lee et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.